
A study analyzing data from NHANES 2007–2010 involving 11,033 US adults found a significant association between elevated C-reactive protein (CRP) levels and an increased risk of kidney stones. As CRP levels rose, kidney stone prevalence increased across quartiles (Quartile 1: 7.59%; Quartile 4: 10.89%). The study revealed a positive correlation between CRP and kidney stone risk, with a 69% higher risk in the highest CRP quartile. Gender, BMI, diabetes, hypertension, CKD, and lifestyle factors did not alter this association. The findings suggest that CRP could serve as a valuable biomarker for risk assessment and management of kidney stones.
Like
Save
Share